High-dose sublingual immunotherapy in children at 8-year follow-up.
Salvatore
S
Leonardi
Lucia
L
Spicuzza
Mario
M
La Rosa
D000286:Administration, Sublingual; D000293:Adolescent; D052179:Antigens, Plant / Q000008:administration & dosage / Q000276:immunology / Q000627:therapeutic use; D001249:Asthma / Q000517:prevention & control; D003233:Conjunctivitis, Allergic / Q000150:complications / Q000276:immunology* / Q000628:therapy*; D003888:Desensitization, Immunologic / Q000379:methods*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D006967:Hypersensitivity / Q000517:prevention & control; D008297:Male; D032403:Parietaria / Q000737:chemistry / Q000276:immunology; D011058:Pollen / Q000737:chemistry / Q000276:immunology; D006255:Rhinitis, Allergic, Seasonal / Q000150:complications / Q000276:immunology* / Q000628:therapy*; D012882:Skin Tests; D016896:Treatment Outcome; D055815:Young Adult
D052179:Antigens, Plant